Dorothy Agyemang, PharmD '23, is making waves as a post-doctoral USMA oncology fellow at GSK, a global biopharma company, where she specializes in cutting-edge treatments for ovarian and endometrial cancers. Her dynamic role involves strategic collaborations with internal teams, engaging with influential key opinion leaders and external experts, and crafting impactful training programs. Dr. Agyemang's ability to transform clinical trial data into actionable insights is driving innovative medical strategies. Her inspiring journey began with a PharmD from the University of Colorado, where her passion for oncology led her to a pivotal role in medical affairs, allowing her to make a significant impact on patient care through strategic and scientific communication.